T1	p 60 90	temporomandibular joint pain .
T2	p 150 186	temporomandibular ( TMJ ) joint pain
T3	p 255 317	. Twenty subjects , who have TMJ pain , were included for this
T4	p 373 387	group ( n = 10
T5	i 16 42	indomethacin phonophoresis
T6	i 120 146	indomethacin phonophoresis
T7	i 221 239	placebo-controlled
T8	i 360 372	experimental
T9	i 385 412	10 ) or the control group (
T10	i 420 423	) .
T11	i 456 499	application of ultrasound massage ( 1.0 MHz
T12	i 519 529	continuous
T13	i 537 538	)
T14	i 587 592	joint
T15	i 611 646	medium , 1 % indomethacin cream was
T16	i 673 712	group and placebo cream for the control
T17	i 1096 1122	indomethacin phonophoresis
T18	o 743 795	post-treatment pain levels and pain sensitivity were
T19	o 810 888	visual analogue scales ( VAS ) and pressure pain threshold ( PPT ) . Mean data
T20	o 904 922	post-treatment VAS
T21	o 955 973	post-treatment PPT
T22	o 1144 1165	pain relieving effect
T23	o 1179 1183	pain